Monthly Archives: March 2017

Making the Leap from Student to Industry Professional: Introducing the YPC…

By | March 31, 2017

The Young Professionals Committee (YPC) would like to introduce ourselves by showcasing each of the current committee members, telling you a little bit about ourselves and the paths our careers have taken.  To start, I have been the chair of the YPC for 2-3 years.  I work at Thermo Fisher Scientific, which is a supplier… Read More »

Flexion Stock Soars on Report of Sanofi Takeover

By | March 30, 2017

As reported by Robert Weisman in The Boston Globe, following a report that Burlington-based Flexion Therapeutics is negotiating a sale to French drug giant Sanofi, Flexion shares rose more than 33 percent. Spokeswomen for Sanofi and Flexion — which has a promising knee pain drug up before US regulators — declined to comment. The purchase… Read More »

Is Continuous Manufacturing in Your Future?

By | March 29, 2017

Is continuous manufacturing in your future? After all, the technology to enable continuous manufacturing of biopharmaceuticals is rapidly being developed. After attending the Chapter’s educational program at Takeda Pharmaceuticals on March 16, my conclusion is that continuous manufacturing is definitely in our future but, as with past transformations in technology, adoption by industry will be… Read More »

Arrakis Therapeutics to Target RNA with Small-Molecule Medicines

By | March 23, 2017

Waltham-based Arrakis Therapeutics has completed a $38 million Series A financing led by Canaan Partners with participation by Pfizer, Celgene, and biotech industry leader Henri Termeer, among others. Arrakis was founded with a vision to create a proprietary, transformational discovery platform that identifies small-molecule drugs that act directly on disease-causing RNA.  The company was established… Read More »

Vertex to Acquire Concert Pharmaceuticals’ Drug for Treatment of Cystic Fibrosis

By | March 23, 2017

Vertex Pharmaceuticals has agreed to acquire CTP-656 from Lexington-based Concert Pharmaceuticals. CTP-656 is an investigational cystic fibrosis transmembrane conductance regulator (CFTR) potentiator that has the potential to assist in treating the underlying cause of cystic fibrosis (CF). As part of the agreement, Vertex will pay Concert $160 million in cash for worldwide development and commercialization… Read More »

WPI’s BETC Offers Free Undergrad Biotech Training Programs

By | March 16, 2017

The Biomanufacturing Education and Training Center (BETC) at Worcester Polytechnic Institute is hosting three student training sessions in March and April as part of our Undergraduate Student Training Program. The goal is to provide undergraduate students with hands-on learning opportunities that can be beneficial as they prepare for a career in the biotech industry. These… Read More »

Free Info Session for Professional Science Master’s (PSM) in Biotechnology at FSU

By | March 16, 2017

Are you thinking of expanding your professional education with a Master’s Degree? If so, you are invited to attend a free information session to learn more about Framingham State University’s Professional Science Master’s (PSM) Degree in Biotechnology and Quality Assurance. The session will take place Thursday, March 23, 5:00-6:30pm at the Hemenway Annex Building, Room… Read More »